| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 16,278 | 15,464 | 10,954 | 8,968 | | Cost of Revenue | 5,758 | 3,991 | 4,868 | 3,378 | | | Gross Profit | 10,520 | 11,473 | 6,087 | 5,590 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,150 | 6,463 | 3,004 | 3,677 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 653 | 646 | 511 | 435 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,717 | 4,364 | 2,572 | 1,478 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 22 | 26 | 43 | 54 | | Earnings Before Interest And Taxes | 3,666 | 4,390 | 2,793 | 1,666 | | Interest Expense | 701 | 677 | 462 | 337 | | Income Before Tax | 2,965 | 3,713 | 2,331 | 1,330 | | Income Tax Expense | 1,136 | 1,108 | 548 | 152 | | Minority Interest | (73) |
-
| 178 | 135 | | | | Net Income From Continuing Ops | 1,829 | 2,605 | 1,783 | 1,178 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,829 | 2,605 | 1,783 | 1,178 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,829 | $2,605 | $1,783 | $1,178 |
|
2.99% Nasdaq 
0.42 (3.10%) 
Income Statement
